Top Markets
Coin of the day
Chimin Health Management Co., Ltd. Chimin Health Management Co., Ltd.

Chimin Health Management Co., Ltd.

603222
Peringkat dalam Saham #12067
Chimin Health Management Co., Ltd., formerly known as Zhejiang Chimin... Chimin Health Management Co., Ltd., formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd., is a Chinese enterprise specializing in the research, production, and distribution of pharmaceuticals for human use and medical apparatus. Its product offerings include diverse medical packaging options, such as non-PVC soft bags with various valve configurations (e.g., double-tube double valves, single valves, single-tube double valves), plastic bottles, and other specialized containers. The company also supplies an extensive array of injection and infusion devices, encompassing safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, as well as standard and precision filter infusion sets. Beyond these, Chimin Health Management provides in-vitro diagnostic products, hemodialysis supplies, and delivers medical services. The firm was established in 1996 and maintains its principal operations in Huangyan, China.
Harga Saham
$1.19
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$623.96M
Perubahan (1 hari)
-0.49%
Perubahan (1 tahun)
-26.45%
Negara
CN
Perdagangan Chimin Health Management Co., Ltd. (603222)

Kategori

Laba untuk Chimin Health Management Co., Ltd. (603222)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Chimin Health Management Co., Ltd., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Chimin Health Management Co., Ltd. dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH